These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4290376)

  • 1. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Smilo RP; Earll JM; Forsham PH
    Metabolism; 1967 Apr; 16(4):374-7. PubMed ID: 4290376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis.
    Carey RM; Orth DN; Hartmann WH
    J Clin Endocrinol Metab; 1973 Mar; 36(3):482-7. PubMed ID: 4119547
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    Crystal RG; Rose LI; Jagger PI; Lauler DP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Present state of the dynamic studies of the adrenal cortex (excepting and aldosterone function)].
    Bricaire H; Leprat J; Luton JP
    Presse Med (1893); 1968 Nov; 76(45):2157-60. PubMed ID: 4305257
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenocortical steroidogenesis and aminoglutethimide (A. G.). II. Cytochemical and ultrastructural changes. Pratical and theoretical values.
    Touitou Y; Legrand JC; Desgrez P
    Biomedicine; 1973 Jul; 18(4):272-8. PubMed ID: 4373092
    [No Abstract]   [Full Text] [Related]  

  • 9. Cushing's syndrome with a paradoxical response to dexamethasone.
    French FS; Macfie JA; Baggett B; Williams TF; Van Wyk JJ
    Am J Med; 1969 Oct; 47(4):619-24. PubMed ID: 4309844
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoglutethimide in functioning adrenal carcinoma: case report.
    Kumar RS; Kamitsuna S; Cole VW
    South Med J; 1969 Feb; 62(2):225-7. PubMed ID: 5766457
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of urinary excretion of steroids in Cushing's syndrome.
    Martin MM; Hamman BL
    J Clin Endocrinol Metab; 1966 Mar; 26(3):257-67. PubMed ID: 4286016
    [No Abstract]   [Full Text] [Related]  

  • 12. Amino-glutethimide (elipten) in adenocortical carcinoma.
    Miranda-Zetterstrand N; Díaz-Bonet L; Pagán-Sáez H; Rosaly de Jirau W
    Bol Asoc Med P R; 1968 Dec; 60(12):611-8. PubMed ID: 5253414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 14. [Broncho-pulmonary cancer with true or degraded hypercorticism].
    Brun J; Revol A; Queneau P
    Presse Med (1893); 1969 Nov; 77(51):1891-4. PubMed ID: 4312445
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1550-7. PubMed ID: 6075585
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M; Maisey MN
    Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Functional exploration of the adrenal cortex in basal and dynamic conditions in hypercorticism of the Cushing type].
    Minozzi M; Faggiano M; Salerno M; Lombardi G; Nunziata V
    Folia Endocrinol; 1968 Jun; 21(3):292-311. PubMed ID: 4304524
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of aminoglutethimide in the treatment of adrenal gland hyperfunction].
    Neumann P; Knappe G; Stahl F; Kublun G; Bruns W; Wulfert P
    Z Gesamte Inn Med; 1979 May; 34(9):247-53. PubMed ID: 225896
    [No Abstract]   [Full Text] [Related]  

  • 19. APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS.
    BROOKS RV; DUPRE J; GOGATE AN; MILLS IH; PRUNTY FT
    J Clin Endocrinol Metab; 1963 Aug; 23():725-36. PubMed ID: 14059549
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical management of adrenocortical tumors with Cushing's syndrome.
    Scott HW; Foster JH; Rhamy RK; Klatte E; Liddle GW
    Ann Surg; 1971 Jun; 173(6):892-905. PubMed ID: 4325382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.